Lupin Stock Reaches 52-Week High After Six Months of Continuous Gains

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Lupin Shares Soar to 52-Week High on Strong Q3, Biosimilar Pipeline

Lupin, Lupin share price, Lupin stock, Lupin shares, Lupin 52 week high, Lupin shares hit 52 week high, Lupin shares gain, Lupin guidance, Lupin target,

C

CNBC TV18•05-03-2026, 12:19

Lupin Shares Soar to 52-Week High on Strong Q3, Biosimilar Pipeline

•Lupin shares hit a fresh 52-week high on Thursday, March 5, after six consecutive months of gains since September 2025.
•The stock rose 11% this year, outperforming the Nifty Pharma index's 1.2% gain.
•Q3 revenue surged 28% to ₹7,167 crore with margins expanding to 31.6%; US sales reached a record $350 million.
•Company targets $1 billion in US sales this fiscal year and plans five biosimilar launches over the next five years.
•Strategic focus includes India growth, CDMO foray, and M&A for specialty assets in US, Europe, and India.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Lupin said the US drug regulator has classified its inspection of the Pithampur Unit 2 manufacturing facility as 'official action indicated' (OAI).

The US Food and Drug Administration (USFDA) had conducted inspections at the facility from July 8 to July 17, 2025, and closed it by issuing Form 483 with four observations.

Lupin Q3 Net Profit Jumps 38% on Strong US Sales, Divestment Gains

Lumax Auto Tech | Among the nine names highlighted by SBI Securities, Lumax Auto Tech has the highest potential upside. The brokerage has a price target of ₹854 on the stock, which implies a potential upside of 51% from current levels.

Lumax Shares Soar 20% to 52-Week High on Robust Q3 Earnings

सिटी ने Lupin के शेयर के लिए 2540 रुपये प्रति शेयर के टारगेट प्राइस के साथ 'बाय' रेटिंग दी है।

Lupin Shares Poised for 14% Jump Post Q3 Results: Brokerages Rate 'Buy'

Lumax Industries का स्टॉक 20% बढ़कर 6,136.30 रुपये पर बंद हुआ।

Lumax Industries Shares Soar 20% on Robust Q3 Earnings, Hits 52-Week High

Lupin said the US drug regulator has classified its inspection of the Pithampur Unit 2 manufacturing facility as 'official action indicated' (OAI).

The US Food and Drug Administration (USFDA) had conducted inspections at the facility from July 8 to July 17, 2025, and closed it by issuing Form 483 with four observations.

Lupin's Ankleshwar Facility Gets 2 US FDA Observations; Q3 Profit Up 37.5%

दिसंबर 2025 तिमाही में LIC का शुद्ध कंसोलिडेटेड मुनाफा सालाना आधार पर 17.4 प्रतिशत बढ़ गया।

LIC Shares Soar 7% After Strong Q3 Results, Net Profit Jumps 17.4%